The Melbourne Newsroom

How well people with newly diagnosed epilepsy respond to their first drug treatment, may signal the likelihood that they will continue to have uncontrolled seizures according to University of Melbourne Chair of Neurology Professor Patrick Kwan.

Brain damage continues to develop and evolve for months after a traumatic brain injury (TBI), revealing a potential target for treatments to improve brain trauma, new research led by the University of Melbourne has found.

Scientists at The Royal Melbourne Hospital and the University of Melbourne have discovered the cells that cause a common type of childhood leukaemia – T cell Acute Lymphoblastic Leukaemia (T-ALL). Targeting of these cells may lead to improved treatments for this disease and help prevent relapse.

The team, led by Dr Matthew McCormack and Dr David Curtis of the Rotary Bone Marrow Research Laboratories and the University’s Department of Medicine at The Royal Melbourne Hospital, made the discovery whilst studying mice prone to developing this leukaemia.

Prominent international psychiatrist and neuropathologist Professor Ian Everall has been appointed as the new Cato Chair and Head of the University of Melbourne’s Department of Psychiatry based at Melbourne Health, Royal Melbourne Hospital.